Chondrosarcoma: With Updates on Molecular Genetics

Chondrosarcoma (CHS) is a malignant cartilage-forming tumor and usually occurs within the medullary canal of long bones and pelvic bones. Based on the morphologic feature alone, a correct diangosis of CHS may be difficult, Therefore, correlation of radiological and clinicopathological features is mandatory in the diagnosis of CHS. The prognosis of CHS is closely related to histologic grading, however, histologic grading may be subjective with high inter-observer variability. In this paper, we present histologic grading system and clinicopathological and radiological findings of conventional CHS. Subtypes of CHSs, such as dedifferentiated, mesenchymal, and clear cell CHSs are also presented. In addition, we introduce updated cytogenetic and molecular genetic findings to expand our understanding of CHS biology. New markers of cell differentiation, proliferation, and cell signaling might offer important therapeutic and prognostic information in near future.

[1]  S. Stringer,et al.  No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. , 2010, The American journal of pathology.

[2]  B. Alman,et al.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets , 2010, Nature Reviews Cancer.

[3]  E. Rushing,et al.  Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. , 2010, Human pathology.

[4]  M. Wiweger,et al.  Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma , 2010, Laboratory Investigation.

[5]  P. Anract,et al.  Chondrosarcomes dédifférenciés : revue iconographique radio-pathologique , 2010 .

[6]  J. Bovée.  EXTra hit for mouse osteochondroma , 2010, Proceedings of the National Academy of Sciences.

[7]  A. Llombart‐Bosch,et al.  COX-2 expression in chondrosarcoma: a role for celecoxib treatment? , 2010, European journal of cancer.

[8]  Kevin B. Jones,et al.  A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes , 2010, Proceedings of the National Academy of Sciences.

[9]  Raju Vaishya.  Section Editor's Reply , 2009, Definitions.

[10]  L. Sangiorgi,et al.  Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb) , 2009, Human mutation.

[11]  P. Hogendoorn,et al.  Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes , 2009, Modern Pathology.

[12]  M. Hameed,et al.  Genome profiling of chondrosarcoma using oligonucleotide array-based comparative genomic hybridization. , 2009, Cancer genetics and cytogenetics.

[13]  L. Koniaris,et al.  Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. , 2009, The Journal of bone and joint surgery. American volume.

[14]  Saskia Le Cessie,et al.  Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors , 2009, The American journal of surgical pathology.

[15]  M. Vikkula,et al.  PTHR1 mutations associated with Ollier disease result in receptor loss of function. , 2008, Human molecular genetics.

[16]  H. Gelderblom,et al.  The clinical approach towards chondrosarcoma. , 2008, The oncologist.

[17]  S. Pannier,et al.  Hereditary multiple exostoses and enchondromatosis. , 2008, Best practice & research. Clinical rheumatology.

[18]  D. Biau,et al.  Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. , 2007, European journal of cancer.

[19]  W. Chow.  Update on chondrosarcomas , 2007, Current opinion in oncology.

[20]  A. Cleton-Jansen,et al.  The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. , 2007, Journal of the National Cancer Institute.

[21]  J. Hunt,et al.  Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. , 2006, Human pathology.

[22]  F. Sim,et al.  Survivorship Analysis in Patients with Periosteal Chondrosarcoma , 2006, Clinical orthopaedics and related research.

[23]  T. Hasegawa,et al.  Cyclooxygenase-2 overexpression associated with a poor prognosis in chondrosarcomas. , 2006, Human pathology.

[24]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[25]  T. Aigner,et al.  Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma , 2006, Pathology.

[26]  J. Nishio,et al.  Cytogenetic findings in clear cell chondrosarcoma. , 2005, Cancer genetics and cytogenetics.

[27]  A. Cleton-Jansen,et al.  Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas , 2005, The Journal of pathology.

[28]  A. Cleton-Jansen,et al.  Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C , 2004, Human mutation.

[29]  F. Sim,et al.  Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. , 2004, The Journal of bone and joint surgery. American volume.

[30]  R. Sciot,et al.  Molecular analysis of the INK4A/INK4A‐ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression , 2004, The Journal of pathology.

[31]  T. Koyama,et al.  Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation , 2003, Skeletal Radiology.

[32]  A. Wilson,et al.  From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  P. Hogendoorn,et al.  Diagnosis and prognosis of chondrosarcoma of bone , 2002, Expert review of molecular diagnostics.

[34]  K. Unni,et al.  Translocation der(13;21)(q10;q10) in Skeletal and Extraskeletal Mesenchymal Chondrosarcoma , 2002, Modern Pathology.

[35]  T. Aigner,et al.  Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas , 2002, Cancer.

[36]  S. Chi,et al.  Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma. , 2001, International journal of oncology.

[37]  A. Cleton-Jansen,et al.  Up-Regulation of PTHrP and Bcl-2 Expression Characterizes the Progression of Osteochondroma towards Peripheral Chondrosarcoma and Is a Late Event in Central Chondrosarcoma , 2000, Laboratory Investigation.

[38]  D J Flemming,et al.  Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[39]  J. Ro,et al.  Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma. , 2000, Oncology reports.

[40]  F. Sim,et al.  Dedifferentiated clear cell chondrosarcoma. , 2000, The American journal of surgical pathology.

[41]  N. Weidner,et al.  Immunohistochemistry of small round-cell tumors. , 2000, Seminars in diagnostic pathology.

[42]  J. Bloem,et al.  Cartilaginous tumors: fast contrast-enhanced MR imaging. , 2000, Radiology.

[43]  A. Cleton-Jansen,et al.  Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis , 1999, The Journal of pathology.

[44]  G. Nielsen,et al.  Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. , 1999, The American journal of surgical pathology.

[45]  A. Cleton-Jansen,et al.  EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. , 1999, American journal of human genetics.

[46]  D. Ilstrup,et al.  Primary chondrosarcoma of long bones and limb girdles , 1998, Cancer.

[47]  D J Flemming,et al.  Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[48]  A. Huvos,et al.  p53 Mutations in Chondrosarcoma , 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[49]  P. Swanson,et al.  Clear cell tumors of bone. , 1997, Seminars in diagnostic pathology.

[50]  T. Pope,et al.  Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma. , 1997, AJR. American journal of roentgenology.

[51]  T. Ozaki,et al.  Secondary chondrosarcoma in osteochondromas. Medullary extension in 15 of 45 cases. , 1997, Acta orthopaedica Scandinavica.

[52]  F. Sim,et al.  Chondrosarcoma of small bones of the hands and feet , 1997, Cancer.

[53]  J. Mirra,et al.  Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology , 1997, Skeletal Radiology.

[54]  M. Ostrowski,et al.  Lesions of the bones of the hands and feet. , 1997, The American journal of surgical pathology.

[55]  P. Fenton,et al.  Juxtacortical dedifferentiated chondrosarcoma from a primary periosteal chondrosarcoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[56]  J. Bloem,et al.  Cartilaginous tumors: correlation of gadolinium-enhanced MR imaging and histopathologic findings. , 1993, Radiology.

[57]  K. Unni,et al.  Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases , 1986, Cancer.

[58]  J. Mirra,et al.  A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. , 1985, Clinical orthopaedics and related research.

[59]  T. Nojima,et al.  Periosteal chondroma and periosteal chondrosarcoma , 1985, The American journal of surgical pathology.

[60]  F. Sim,et al.  Clear cell chondrosarcoma of bone: Observations in 47 cases , 1984, The American journal of surgical pathology.

[61]  P. Picci,et al.  Mesenchymal chondrosarcoma of bone and soft tissues , 1983, Cancer.

[62]  F. Bertoni,et al.  Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities. , 1982, The Journal of bone and joint surgery. British volume.

[63]  M. Romsdahl,et al.  Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading , 1977, Cancer.

[64]  K. Unni,et al.  Periosteal osteogenic sarcoma , 1976, Cancer.

[65]  D. Dahlin,et al.  Mesenchymal chondrosarcoma—observations on 30 new cases , 1971, Cancer.

[66]  W. Marsden.  I and J , 2012 .

[67]  J. Dietemann,et al.  [Dedifferentiated chondrosarcoma: radiologic-pathologic correlation]. , 2010, Journal de radiologie.

[68]  R. Terek.  Recent advances in the basic science of chondrosarcoma. , 2006, The Orthopedic clinics of North America.

[69]  Iroon Polytechniou.  Influence of cultivation temperature on the ligninolytic activity of selected fungal strains , 2006 .

[70]  G. Hermann,et al.  Lesions of juxtacortical origin (surface lesions of bone) , 2004, Skeletal Radiology.

[71]  L. Sehgal,et al.  Γ and B , 2004 .

[72]  Vikas Yadav.  Periosteal chondrosarcoma. , 2003, Orthopedics.

[73]  F. Mertens,et al.  World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .

[74]  R. Grimer,et al.  Experience in the treatment of dedifferentiated chondrosarcoma. , 2000, The Journal of bone and joint surgery. British volume.

[75]  M. Murphey,et al.  Enchondroma and Chondrosarcoma , 2000, Seminars in musculoskeletal radiology.

[76]  J. Mirra,et al.  Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II. Juxtacortical cartilage tumors , 1999, Skeletal Radiology.

[77]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[78]  A. Cohn.  Bone tumors. , 1978, Orthopedics.

[79]  and as an in , 2022 .